BSE Code: | NSE Code: | ISIN: | Sector:
Research Report Detail
|Report Date||Call||Price@Call||Target Price
|Current Status||Time Horizon|
|Closed|| Long (1Y)
Equirus Securities Recommends ‘Buy’ On Dr Reddy’s Laboratories
Equirus Securities expects Dr Reddy20Laboratories20US revenues to grow going forward, in view of the high-value products launched by the company.